DV
Dividend Vision

TGTX — TG Therapeutics Inc.

TG Therapeutics Inc. (TGTX)

Its deepest 1-year drawdown was 26.9%.

TGTX is a single-stock equity holding in TG Therapeutics Inc., a biotechnology company, rather than a diversified ETF. As a concentrated equity position with no dividend distribution rate, it does not function as a traditional income-generating vehicle and carries the risk profile of an individual stock investment. This holding appeals primarily to investors seeking exposure to the biotechnology sector's growth potential rather than dividend income.

TGTX key facts

Asset type
Stock
Asset class
Equity
Inception date
12/14/1995
Distribution frequency
None
Last close
$48.74
Market cap
$7,461,294,080
Average volume
1072500.0
Beta
1.666
Payout ratio
0.0
P/E ratio
17.4695
Forward P/E
60.6061
EPS
$2.79